Medifast (NYSE: MED) director adds 43K shares in open-market buy

Rhea-AI Filing Summary

MEDIFAST INC (MED) director Parsa Kiai reported two indirect open-market purchases of MED common stock on 2026-08-26 totaling 43,150 shares at an average price of $12.2632 per share. The shares are held through Steamboat Capital funds and related entities, and Kiai disclaims beneficial ownership except to the extent of his pecuniary interest.

Insider Trade Summary

Net Buyer: 43,150 shares

Net Buy 2 txns

Insider Kiai Parsa

Role Director

Bought 43,150 shs ($529K)

Type	Security	Shares	Price	Value
Purchase	Common Stock F1, F3, F4	41,975	$12.2632	$515K
Purchase	Common Stock F2, F3, F4	1,175	$12.2632	$14K

Holdings After Transaction: Common Stock — 20,270 shares (Indirect, Notes)

Footnotes (4)

1. F1. Ownership of Steamboat Capital Partners Master Fund, LP (Master) which has delegated investment discretion to Steamboat Capital Partners, LLC (IA).
2. F2. Ownership of Steamboat Capital Partners II, LP (II).
3. F3. Steamboat Capital Partners GP, LLC (GP) is general partner of, and entitled to receive a performance allocation from, each of Master and II. Parsa Kiai ("Kiai") is the Managing Member of GP and IA. Accordingly, Kiai may be deemed to have a pecuniary interest in the shares owned by Master and II. Kiai disclaims beneficial ownership of securities reported hereon except to the extent of his pecuniary interest therein.
4. F4. This is an average price. Actual prices paid for the shares purchased on 8/26/26 and reported on this line range from $12.12 to $12.38. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Key Figures

Shares purchased (Master Fund-related): 41,975 shares of Common Stock Shares purchased (Fund II-related): 1,175 shares of Common Stock Total shares purchased: 43,150 shares of Common Stock +2 more

5 metrics

Shares purchased (Master Fund-related) 41,975 shares of Common Stock Indirect purchase on 2026-08-26 attributed to Steamboat Capital Partners Master Fund, LP

Shares purchased (Fund II-related) 1,175 shares of Common Stock Indirect purchase on 2026-08-26 attributed to Steamboat Capital Partners II, LP

Total shares purchased 43,150 shares of Common Stock Combined indirect open-market purchases on 2026-08-26

Average purchase price $12.2632 per share Weighted average price for purchases on 2026-08-26

Price range for purchases $12.12 to $12.38 per share Actual prices paid for shares purchased on 2026-08-26

Key Terms

indirect ownership, pecuniary interest, performance allocation

3 terms

indirect ownership financial

"All reported MED shares are held indirectly through Steamboat Capital entities"

pecuniary interest financial

"Kiai may be deemed to have a pecuniary interest in the shares"

performance allocation financial

"Steamboat Capital Partners GP, LLC is entitled to receive a performance allocation"

FAQ

What insider transactions did MED (MEDIFAST INC) disclose in this Form 4?

The Form 4 reports that director Parsa Kiai indirectly purchased 43,150 shares of MED common stock on 2026-08-26 in two open-market transactions through Steamboat Capital-related entities.

How many MED (MEDIFAST INC) shares did Parsa Kiai buy and at what price?

Parsa Kiai’s entities purchased 41,975 shares and 1,175 shares of MED common stock, for a total of 43,150 shares, at an average price of $12.2632 per share, with actual prices ranging from $12.12 to $12.38.

Were Parsa Kiai’s MED purchases held directly or indirectly?

All reported MED shares are held indirectly through Steamboat Capital entities, including Steamboat Capital Partners Master Fund, LP and Steamboat Capital Partners II, LP, with related general partner and investment adviser entities involved.

Does Parsa Kiai claim full beneficial ownership of the MED shares?

No. The filing states that Parsa Kiai may be deemed to have a pecuniary interest in shares owned by the Steamboat funds but disclaims beneficial ownership of the securities except to the extent of his pecuniary interest.

Were the MED (MEDIFAST INC) insider purchases made under a Rule 10b5-1 plan?

No. The filing’s Rule 10b5-1 checkbox is not checked, and no footnote indicates that these MED share purchases were made pursuant to a Rule 10b5-1 or other pre-arranged trading plan.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 08/28/2026 - 12:48 PM Accepted by SEC EDGAR 08/28/2026 - 12:47 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Kiai Parsa

(Last) (First) (Middle)

24 MAPLE AVE

(Street)

RYE NEW YORK 10580

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
MEDIFAST INC [ MED ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/26/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/26/2026		P		41,975	A	$12.2632	707,492	I	Notes(1)(3)(4)
Common Stock	08/26/2026		P		1,175	A	$12.2632	20,270	I	Notes(2)(3)(4)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Ownership of Steamboat Capital Partners Master Fund, LP (Master) which has delegated investment discretion to Steamboat Capital Partners, LLC (IA).

2. Ownership of Steamboat Capital Partners II, LP (II).

3. Steamboat Capital Partners GP, LLC (GP) is general partner of, and entitled to receive a performance allocation from, each of Master and II. Parsa Kiai ("Kiai") is the Managing Member of GP and IA. Accordingly, Kiai may be deemed to have a pecuniary interest in the shares owned by Master and II. Kiai disclaims beneficial ownership of securities reported hereon except to the extent of his pecuniary interest therein.

4. This is an average price. Actual prices paid for the shares purchased on 8/26/26 and reported on this line range from $12.12 to $12.38. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

	/s/ Parsa Kiai	08/28/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)